In vivo evaluation of drug dialyzability in a rat model of hemodialysis

PloS One
Masaki FukunagaSumio Hirata

Abstract

It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD rat) and to extrapolate this result to the drug removal rate in HD patients. HD rats received bilateral nephrectomy and HD for 2 h. The dialysis removal of 6 drugs was evaluated in HD rats. Dialysis efficiency, plasma protein binding rate (PBR) and distribution volume (Vd) of drugs were also measured. Furthermore, we examined the correlation between the dialyzability of drug in HD rats and humans and constructed the prediction formula of the drug dialyzability in HD patients. The clearance of urea and creatinine and normalized dialysis dose in HD rats were 0.83 ± 0.07 mL/min, 0.70 ± 0.08 mL/min, and 0.13 ± 0.06, respectively. The drug dialyzability in HD rats was similar to reported clinical data except for doripenem. A higher correlation was observed between drug dialyzability in reported clinical data and HD rats which were adjusted for PBR (r2 = 0.936; p < 0.001) compared to unadjusted (r2 = 0.812; p = 0.009). Therefore, we constru...Continue Reading

References

Mar 20, 1978·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·A RöckelF S Pedersen
Sep 1, 1976·Antimicrobial Agents and Chemotherapy·T MadhavanE L Quinn
Oct 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C A DeSoiJ G Umans
Jan 1, 1992·European Journal of Clinical Pharmacology·J BöhlerP J Schollmeyer
Jul 11, 1992·Kidney International·S M SilverR H Sterns
Jan 1, 1989·European Journal of Clinical Pharmacology·L F PrescottR J Winney
Dec 1, 1988·Clinical Pharmacokinetics·G ZaccaraF Moroni
Jun 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·Y SawadaT Iga
Jan 1, 1984·European Journal of Clinical Pharmacology·T KobariH Hayakawa
May 1, 1980·Neurology·J BruniB J Wilder
Jan 1, 1994·Kidney International·T A PollardB J Maroni
Aug 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J T Daugirdas
May 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K SombolosC Fitili
Jan 1, 1997·Clinical Pharmacokinetics·Y W LamR L Talbert
Oct 12, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·L J Brunner, S Bai
Jan 23, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joanna Q HudsonGeorge M Feldman
Feb 1, 1952·The Australian Journal of Experimental Biology and Medical Science·D A COATS, M L WELLBY
Sep 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert E ArianoSheryl A Zelenitsky
Apr 2, 2009·Biological & Pharmaceutical Bulletin·Yoshimasa TsuchishitaKazuyuki Ueno
Dec 2, 2010·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Shigeru NakaiYoshiharu Tsubakihara
Jan 14, 2011·Blood Purification·Ali J Olyaei, Jessica L Steffl
Jun 1, 2011·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Kazutaka TanoueSumio Hirata
Aug 20, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Loren M BerryZhiyang Zhao
Aug 20, 2014·Infectious Diseases and Therapy·Simon W Lam, Seth R Bauer
Sep 14, 2014·Nature Medicine·Joo H KangDonald E Ingber
Jan 17, 2017·Seminars in Dialysis·John T Daugirdas
Aug 5, 2017·Biological & Pharmaceutical Bulletin·Ryota TanakaHiroki Itoh

❮ Previous
Next ❯

Software Mentioned

Statcel4
Excel
R
STAT
R Foundation for Statistical

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Journal of hygiene, epidemiology, microbiology, and immunology
G K Han
Biochimica Et Biophysica Acta
B BAKAYG TOENNIES
Journal of hygiene, epidemiology, microbiology, and immunology
K H Gan
Current Opinion in Nephrology and Hypertension
Alvin TieuMatthew A Weir
© 2022 Meta ULC. All rights reserved